Effects of Intradialytic Inspiratory Muscle Training on Functional Capacity in Hemodialysis Patients

ConditionHemodialysis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorBaskent University

About this trial

There is a need for long-term sustainable studies that will increase the potential health benefits in hemodialysis patients. Inspiratory muscle training, one of the recommended treatments to increase exercise capacity and quality of life during dialysis treatment in people with chronic renal failure, is a method that can be applied intradialytically, in addition to being easy to apply, cheap and sustainable. It improves functional capacity by increasing respiratory muscle strength. In this context, our study aims to investigate the effects of inspiratory muscle training on functional parameters and on hemodialysis patients with a personalized portable device and to add it to the literature.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Being on hemodialysis for at least 6 months

Being on hemodialysis for 4 hours, 3 days a week

Not having had a transplant

Being able to continue sitting and standing

Disqualifiers

Individuals with communication and/or cognitive problems that are unable to fulfill the assessment and treatment requirements

Patients with uncontrolled cardiac, pulmonary or other systemic diseases

Trial design

Design model

Parallel

Treatments tested in this trial

  • inspiratory muscle training

    Device

    Powerbreathe® threshold resistance loading device (POWERbreathe, HaB International) will be used for this training program that strengthens the inspiratory muscles. The PowerBreathe® device is a threshold device that creates resistance to inspiration. This resistance is created by the spring tension in the device mechanism. The device has a mechanism that is adjusted according to 9 different levels in its mechanism specific to the individuals using it.

Treatment groups

34 Participants
are divided into 2 treatment groups
Group A: Inspiratory Muscle Training GroupExperimental treatment 1 intervention
Group B: controlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Inspiratory muscle strength

The respiratory muscle strength measuring device Power Breathe (Power Breathe, K5, HaB International Ltd England) will be used to assess inspiratory muscle strength. During the assessment, the patient will be asked to sit in a chair with back support and no arm support, with shoulders relaxed, and a nose clip will be used. Patients will be asked to take a deep breath through the device placed in their mouth. The inspiratory force index (S-index) obtained as a result of the measurement will be recorded.

Time frame
The individuals participating in the study will be evaluated twice: before the application (week 0) and after the application (after 12 weeks).

Secondary outcomes

1

Exercise Capacity Assessment

The 6-minute walk test (6MWT), which is clinically easy to apply and reliable, will be used to assess the functional capacity of individuals.The 6-minute walk test (6MWT), which is clinically easy to apply and reliable, will be used to assess the functional capacity of individuals. At the end of 6 minutes, the distance walked in meters (m) will be recorded.

Time frame
The individuals participating in the study will be evaluated twice: before the application (week 0) and after the application (after 12 weeks).

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: